U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
DACETUZUMAB
INN   USAN   WHO-DD  
INN   USAN  
Official Name English
HU-S2C6
Preferred Name English
Dacetuzumab [WHO-DD]
Common Name English
HUS2C6
Code English
SGN-40
Code English
DACETUZUMAB [USAN]
Common Name English
dacetuzumab [INN]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 209305
Created by admin on Mon Mar 31 20:38:19 GMT 2025 , Edited by admin on Mon Mar 31 20:38:19 GMT 2025
NCI_THESAURUS C129822
Created by admin on Mon Mar 31 20:38:19 GMT 2025 , Edited by admin on Mon Mar 31 20:38:19 GMT 2025
FDA ORPHAN DRUG 188004
Created by admin on Mon Mar 31 20:38:19 GMT 2025 , Edited by admin on Mon Mar 31 20:38:19 GMT 2025
NCI_THESAURUS C20401
Created by admin on Mon Mar 31 20:38:19 GMT 2025 , Edited by admin on Mon Mar 31 20:38:19 GMT 2025
Code System Code Type Description
EVMPD
SUB33920
Created by admin on Mon Mar 31 20:38:19 GMT 2025 , Edited by admin on Mon Mar 31 20:38:19 GMT 2025
PRIMARY
FDA UNII
UT59FF4T5X
Created by admin on Mon Mar 31 20:38:19 GMT 2025 , Edited by admin on Mon Mar 31 20:38:19 GMT 2025
PRIMARY
NCI_THESAURUS
C62179
Created by admin on Mon Mar 31 20:38:19 GMT 2025 , Edited by admin on Mon Mar 31 20:38:19 GMT 2025
PRIMARY
WIKIPEDIA
Dacetuzumab
Created by admin on Mon Mar 31 20:38:19 GMT 2025 , Edited by admin on Mon Mar 31 20:38:19 GMT 2025
PRIMARY
DRUG BANK
DB12589
Created by admin on Mon Mar 31 20:38:19 GMT 2025 , Edited by admin on Mon Mar 31 20:38:19 GMT 2025
PRIMARY
INN
8959
Created by admin on Mon Mar 31 20:38:19 GMT 2025 , Edited by admin on Mon Mar 31 20:38:19 GMT 2025
PRIMARY
CAS
880486-59-9
Created by admin on Mon Mar 31 20:38:19 GMT 2025 , Edited by admin on Mon Mar 31 20:38:19 GMT 2025
PRIMARY
SMS_ID
100000127793
Created by admin on Mon Mar 31 20:38:19 GMT 2025 , Edited by admin on Mon Mar 31 20:38:19 GMT 2025
PRIMARY
ChEMBL
CHEMBL1743005
Created by admin on Mon Mar 31 20:38:19 GMT 2025 , Edited by admin on Mon Mar 31 20:38:19 GMT 2025
PRIMARY
USAN
TT-36
Created by admin on Mon Mar 31 20:38:19 GMT 2025 , Edited by admin on Mon Mar 31 20:38:19 GMT 2025
PRIMARY
ACTIVE MOIETY
DACETUZUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966